- Nabis Holdings is a private equity play with global ambitions in the cannabis space
- The company has cannabis investments in Arizona, Michigan and Washington
- INNPF’s management team boasts a track record of boosting valuations
With the establishment of Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), Shay Shnet and Mark Krytiuk seem set for an encore. The pioneering pair are co-founders of MPX Bioceutical (CSE: MPX) and played important roles prior to its merger with iAnthus Capital Holdings Inc. (OTCQX: ITHUF), valued at C$835 million. Now, Shnet and Krytiuk are out to repeat that success with Nabis Holdings, an aptly named investment entity; the name means “repeat performance.” Nabis is targeting vertically integrated cannabis companies with positive EBITDA that are operating in limited license states with large addressable markets.
MPX Bioceutical was founded by Shnet and Krytiuk to focus on developing and operating assets across the global cannabis industry. Shnet, with two decades of experience in senior management roles under his belt, served as vice president of operations and led the company’s efforts to build a portfolio of international cannabis assets. He is especially adept in unearthing unique investment opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines. Mark Krytiuk was vice president of grow operations at MPX Bioceutical and, in that position, supervised the production of medical marijuana and pharma-grade products across North America. Moreover, he has been directly involved in the construction of nine cannabis facilities in three different countries, with budgets ranging up to $30 million.
The dynamic duo has already set the ball rolling. Nabis has executed binding letters of intent (LOI) to invest in the states of Michigan, Arizona and Washington. In Michigan, Nabis plans to invest in seven strategically located properties that have or are eligible for municipal approvals as provisioning centers. In addition, the company plans to acquire a municipally approved property with 10 cultivation licenses and one processing license.
In Arizona, Nabis has executed a binding LOI to acquire full control of Organica Patient Group Inc. (“OPG”) and RDF Management Group (“RDF”). OPG is a fully-integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its operations include the Chino Valley MMJ Dispensary, a 26,000 square foot indoor cultivation and processing center and a 56,600 square foot greenhouse. OPG has its own branded products and an extensive distribution network that covers more than 25 percent of dispensaries in Arizona.
In Washington, Nabis plans to purchase assets from PDT Technologies LLC (“PDT”), which include extraction and production equipment and rights to lease a current production facility. With the acquisition, Nabis will enjoy licensing rights to produce Chong’s Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space.
On completion of its proposed acquisitions, Nabis is shooting for revenues of C$12 million in 2019 and C$116 million by 2020, at a gross margin of 55 percent. Expected EBITDA is forecast at C$3.3 million for 2019 and C$39.4 million for 2020.
For more information, visit the company’s website at www.NabisHoldings.com
NOTE TO INVESTORS: The latest news and updates relating to INNPF are available in the company’s newsroom at http://ibn.fm/INNPF
